Literature DB >> 26493178

Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?

Yalcin Solak1, Kazuomi Kario2, Adrian Covic3, Nathan Bertelsen4, Baris Afsar5, Abdullah Ozkok6, Andrzej Wiecek7, Mehmet Kanbay8.   

Abstract

Hypertension is a very common disease, and office measurements of blood pressure are frequently inaccurate. Ambulatory Blood Pressure Monitoring (ABPM) offers a more accurate diagnosis, more detailed readings of average blood pressures, better blood pressure measurement during sleep, fewer false positives by detecting more white-coat hypertension, and fewer false negatives by detecting more masked hypertension. ABPM offers better management of clinical outcomes. For example, based on more accurate measurements of blood pressure variability, ABPM demonstrates that taking antihypertensive medication at night leads to better controlled nocturnal blood pressure, which translates into less end organ damage and fewer clinical complications of hypertension. For these reasons, albeit some shortcomings which were discussed, ABPM should be considered as a first-line tool for diagnosing and managing hypertension.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; Cardiovascular disease; Hypertension

Mesh:

Substances:

Year:  2015        PMID: 26493178     DOI: 10.1007/s10157-015-1184-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  59 in total

Review 1.  Cardiovascular disease, chronopharmacotherapy, and the molecular clock.

Authors:  Norihiko Takeda; Koji Maemura
Journal:  Adv Drug Deliv Rev       Date:  2010-05-06       Impact factor: 15.470

Review 2.  Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis.

Authors:  Ioannis A Bliziotis; Antonis Destounis; George S Stergiou
Journal:  J Hypertens       Date:  2012-07       Impact factor: 4.844

3.  Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.

Authors:  Roberto Minutolo; Silvio Borrelli; Raffaele Scigliano; Vincenzo Bellizzi; Paolo Chiodini; Bruno Cianciaruso; Felice Nappi; Pasquale Zamboli; Giuseppe Conte; Luca De Nicola
Journal:  Nephrol Dial Transplant       Date:  2007-04-09       Impact factor: 5.992

Review 4.  Prognosis in relation to blood pressure variability: pro side of the argument.

Authors:  Kazuomi Kario
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

Review 5.  Masked hypertension: a phenomenon of measurement.

Authors:  Stanley S Franklin; Eoin O'Brien; Lutgarde Thijs; Kei Asayama; Jan A Staessen
Journal:  Hypertension       Date:  2014-10-06       Impact factor: 10.190

6.  Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study.

Authors:  Alexandros Kasiakogias; Costas Tsioufis; Costas Thomopoulos; Ioannis Andrikou; Dimitrios Aragiannis; Kyriakos Dimitriadis; Dimitrios Tsiachris; Grzegorz Bilo; Skevos Sideris; Konstantinos Filis; Gianfranco Parati; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2015-02       Impact factor: 4.844

Review 7.  Resistant hypertension.

Authors:  Norman M Kaplan
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

8.  Blood pressure and mortality among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

9.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

Authors:  José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Journal:  Lancet       Date:  2007-10-06       Impact factor: 79.321

10.  2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.

Authors:  Ramón C Hermida; Michael H Smolensky; Diana E Ayala; Francesco Portaluppi
Journal:  Chronobiol Int       Date:  2013-04       Impact factor: 2.877

View more
  6 in total

1.  Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.

Authors:  Raija Lithovius; Daniel Gordin; Carol Forsblom; Markku Saraheimo; Valma Harjutsalo; Per-Henrik Groop
Journal:  Diabetologia       Date:  2018-05-24       Impact factor: 10.122

2.  Short-term blood pressure variability and long-term blood pressure variability: which one is a reliable predictor for recurrent stroke.

Authors:  Y Tao; J Xu; B Song; X Xie; H Gu; Q Liu; L Zhao; Y Wang; Y Xu; Y Wang
Journal:  J Hum Hypertens       Date:  2017-04-27       Impact factor: 3.012

3.  The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications.

Authors:  Francesca Santilli; Paola Simeone; Damiano D'Ardes; Giovanni Davì
Journal:  Hypertens Res       Date:  2016-03-17       Impact factor: 3.872

4.  Effect of Social, regional, and education status and season on blood pressure.

Authors:  Aslihan Yerlikaya; Baris Afsar; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-20       Impact factor: 3.738

Review 5.  Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure.

Authors:  Amy McMahon; Helene McNulty; Catherine F Hughes; J J Strain; Mary Ward
Journal:  Nutrients       Date:  2016-11-11       Impact factor: 5.717

6.  The assessment of hypertension in kidney transplant patients: time to change our approach?

Authors:  Atalay Demiray; Mehmet Kanbay
Journal:  Clin Kidney J       Date:  2021-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.